Jun 15, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
MHRA Gives An Insight Into New ICH S9 Guidelines At Clinical Development In Oncology,
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2452187" data-attributes="member: 124445"><p>JW McBlane, Clinical Assessor, MHRA will be giving an exclusive insight into the agency's views of the new ICH S9 guidelines. His case study, Early Stage Clinical Trials In Patients With Advanced Cancer - ICH S9 And Recent Regulatory Developments, is part of the 2nd Annual Clinical Development in Oncology conference, taking place in London, 15-16 March 2011. This update will allow specialists to begin trials on the basis of reduced preclinical data sets and understand what the UK agency deems acceptable...<a href="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/6WvIN5ykT9w" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/6WvIN5ykT9w/3Pdh" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2452187, member: 124445"] JW McBlane, Clinical Assessor, MHRA will be giving an exclusive insight into the agency's views of the new ICH S9 guidelines. His case study, Early Stage Clinical Trials In Patients With Advanced Cancer - ICH S9 And Recent Regulatory Developments, is part of the 2nd Annual Clinical Development in Oncology conference, taking place in London, 15-16 March 2011. This update will allow specialists to begin trials on the basis of reduced preclinical data sets and understand what the UK agency deems acceptable...[URL="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/0/da"][IMG]http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/1/da"][IMG]http://feedads.g.doubleclick.net/~a/RTl3Ajhi7hPRaQn0RRiXAiemfTI/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/6WvIN5ykT9w[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/6WvIN5ykT9w/3Pdh]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top